VIDO-InterVac at the University of Saskatchewan. (Photo: Debra Marshall)

USask’s VIDO-InterVac and the National Research Council of Canada collaborate to advance development of vaccine against COVID-19

Posted on

Key research and development organizations to leverage Canadian expertise and technologies in battle against COVID-19.

The University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) and the National Research Council of Canada (NRC) today announced a collaboration to work together to accelerate the development and production of a candidate COVID-19 antigen in mammalian cells…..
 
Tags:COVID-19HealthResearch

Read More Impact Stories

Posted on

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Read more
Posted on

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Read more
Posted on

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Read more
View All Impact Stories